Evidence map›Paper›PMID 31265257›Full record

ArticleAnalytical chemistry2019

Secreted Metabolome of Human Macrophages Exposed to Methamphetamine.

Katarzyna Pawlak, Katarzyna Lech, Akou Vei, Sydney Burch, Sarah Zieschang, Spencer Jaquet, Fang Yu, Emma Harwood, Brenda Morsey, Howard S Fox and 1 more

Abstract read
In one paragraph

Article in Analytical chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Katarzyna PawlakDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.ORCID 0000-0002-7200-3468
Katarzyna LechDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.ORCID 0000-0003-4476-2261
Akou VeiDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.
Sydney BurchDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.
Sarah ZieschangDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.
Spencer JaquetDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.
Fang YuDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.
Emma HarwoodDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.
Brenda MorseyDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.
Howard S FoxDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.ORCID 0000-0003-2032-374X
Pawel CiborowskiDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 University of Nebraska Medical Center , Omaha , Nebraska 68198-5800 , United States.ORCID 0000-0001-6912-101X

Funding

Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
Macrophage, Meth, HIV and Histones: An InterplayR01DA043258 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI CIBOROWSKI, PAWEL S, FOX, HOWARD S · 2016 to 2020
$3.1M
NIDA NIH HHS R01 DA043258NIMH NIH HHS P30 MH062261
6 · The paper itself

Abstract

Macrophages comprise a major component of the human innate immune system that is involved in maintaining homeostasis and responding to infections or other insults. Besides cytokines and chemokines, macrophages presumably influence the surrounding environment by secreting various types of metabolites. Characterization of secreted metabolites under normal and pathological conditions is critical for understanding the complex innate immune system. To investigate the secreted metabolome, we developed a novel workflow consisting of one Reverse Phase (RP) C18 column linked in tandem with a Cogent cholesterol-modified RP C18. This system was used to compare the secreted metabolomes of human monocyte-derived macrophages (hMDM) under normal conditions to those exposed to methamphetamine (Meth). This new experimental approach allowed us to measure 92 metabolites, identify 11 of them as differentially expressed, separate and identify three hydroxymethamphetamine (OHMA) isomers, and identify a new, yet unknown metabolite with a

Indexed as

Chromatography, LiquidHumansLiquid-Liquid ExtractionMacrophagesMass SpectrometryMetabolomeMetabolomicsMethamphetamineSolid Phase ExtractionMethamphetamine

Identifiers

PMID31265257
PMCPMC6903799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.